These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 35972133)

  • 21. Emerging cystic fibrosis pathogens and the microbiome.
    Mahenthiralingam E
    Paediatr Respir Rev; 2014 Jun; 15 Suppl 1():13-5. PubMed ID: 24832700
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Willsey GG; Eckstrom K; LaBauve AE; Hinkel LA; Schutz K; Meagher RJ; LiPuma JJ; Wargo MJ
    J Bacteriol; 2019 Aug; 201(15):. PubMed ID: 31109991
    [No Abstract]   [Full Text] [Related]  

  • 23. Ecological patterns and processes of temporal turnover within lung infection microbiota.
    Gavillet H; Hatfield L; Jones A; Maitra A; Horsley A; Rivett D; van der Gast C
    Microbiome; 2024 Mar; 12(1):63. PubMed ID: 38523273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibrosis.
    Sibley CD; Parkins MD; Rabin HR; Surette MG
    Curr Opin Investig Drugs; 2009 Aug; 10(8):787-94. PubMed ID: 19649923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled antibiotics in Cystic Fibrosis (CF) and non-CF bronchiectasis.
    Tay GT; Reid DW; Bell SC
    Semin Respir Crit Care Med; 2015 Apr; 36(2):267-86. PubMed ID: 25826593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
    Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
    J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Innovative Protocol for Metaproteomic Analyses of Microbial Pathogens in Cystic Fibrosis Sputum.
    Graf AC; Striesow J; Pané-Farré J; Sura T; Wurster M; Lalk M; Pieper DH; Becher D; Kahl BC; Riedel K
    Front Cell Infect Microbiol; 2021; 11():724569. PubMed ID: 34513734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis Reveals Potential Influence of Oxidative Stress on the Airway Microbiomes of Cystic Fibrosis Patients.
    Shi X; Gao Z; Lin Q; Zhao L; Ma Q; Kang Y; Yu J
    Genomics Proteomics Bioinformatics; 2019 Dec; 17(6):590-602. PubMed ID: 32171662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of cycled inhaled aztreonam on the cystic fibrosis (CF) lung microbiome.
    Heirali AA; Acosta N; Storey DG; Workentine ML; Somayaji R; Laforest-Lapointe I; Leung W; Quon BS; Berthiaume Y; Rabin HR; Waddell BJ; Rossi L; Surette MG; Parkins MD
    J Cyst Fibros; 2019 Nov; 18(6):829-837. PubMed ID: 30857926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liquid Chromatography Mass Spectrometry Detection of Antibiotic Agents in Sputum from Persons with Cystic Fibrosis.
    Gallagher T; Riedel S; Kapcia J; Caverly LJ; Carmody L; Kalikin LM; Lu J; Phan J; Gargus M; Kagawa M; Leemans SW; Rothman JA; Grun F; LiPuma JJ; Whiteson KL
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33139284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymicrobial Interactions in the Cystic Fibrosis Airway Microbiome Impact the Antimicrobial Susceptibility of
    Reece E; Bettio PHA; Renwick J
    Antibiotics (Basel); 2021 Jul; 10(7):. PubMed ID: 34356747
    [No Abstract]   [Full Text] [Related]  

  • 32. Persistent Legionnaires' Disease and Associated Antibiotic Treatment Engender a Highly Disturbed Pulmonary Microbiome Enriched in Opportunistic Microorganisms.
    Pérez-Cobas AE; Ginevra C; Rusniok C; Jarraud S; Buchrieser C
    mBio; 2020 May; 11(3):. PubMed ID: 32430469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
    Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
    PLoS One; 2016; 11(6):e0156807. PubMed ID: 27355625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complex and unexpected outcomes of antibiotic therapy against a polymicrobial infection.
    Ghuneim LJ; Raghuvanshi R; Neugebauer KA; Guzior DV; Christian MH; Schena B; Feiner JM; Castillo-Bahena A; Mielke J; McClelland M; Conrad D; Klapper I; Zhang T; Quinn RA
    ISME J; 2022 Sep; 16(9):2065-2075. PubMed ID: 35597889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome.
    Vieira J; Gallagher T; Sui HY; Jesudasen S; Whiteson K; O'Toole GA; Hanselmann K; Lai PS
    J Vis Exp; 2021 Aug; (174):. PubMed ID: 34424248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Same Exposure but Two Radically Different Responses to Antibiotics: Resilience of the Salivary Microbiome versus Long-Term Microbial Shifts in Feces.
    Zaura E; Brandt BW; Teixeira de Mattos MJ; Buijs MJ; Caspers MP; Rashid MU; Weintraub A; Nord CE; Savell A; Hu Y; Coates AR; Hubank M; Spratt DA; Wilson M; Keijser BJ; Crielaard W
    mBio; 2015 Nov; 6(6):e01693-15. PubMed ID: 26556275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis.
    Sherrard LJ; Tunney MM; Elborn JS
    Lancet; 2014 Aug; 384(9944):703-13. PubMed ID: 25152272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective Sweeps and Parallel Pathoadaptation Drive Pseudomonas aeruginosa Evolution in the Cystic Fibrosis Lung.
    Diaz Caballero J; Clark ST; Coburn B; Zhang Y; Wang PW; Donaldson SL; Tullis DE; Yau YC; Waters VJ; Hwang DM; Guttman DS
    mBio; 2015 Sep; 6(5):e00981-15. PubMed ID: 26330513
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Orazi G; O'Toole GA
    mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT.
    Langton Hewer SC; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Sutton L; Clayton D; Arch B; Tanajewski Ł; Berdunov V; Williamson PR
    Health Technol Assess; 2021 Nov; 25(65):1-128. PubMed ID: 34806975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.